Science Firsthand
Scientists at Bristol Myers Squibb are motivated by the power of science to transform how we research, develop and deliver the next generation of treatment options to more patients.
Science Firsthand is a storytelling series that highlights years of progress in complex science through the eyes of our R&D experts. See how we have pioneered paths forward and are continually expanding upon learnings from our differentiated research platforms and beyond.
Featured leaders
“Typically, drug discovery timelines have been in the scale of decades. …. Leveraging predictive molecule invention upfront allows us to accelerate drug discovery in a way that increases our chances of progressing the best molecules.”
Payal Sheth, PhD, vice president, Discovery Biotherapeutics, Lead Discovery and Optimization
“New modalities do not come along very often, and so when they do, there is great promise. It’s one of the main motivations for our BMS scientists to begin to push the limits, to rapidly iterate and drive forth novel medications for patients who need them most.”
Neil Bence, senior vice president, Protein Homeostasis TRC, San Diego site head
"Cell therapy is incredibly exciting to work on because it really is a team sport that requires careful coordination."
Mike Burgess, MD, PhD, senior vice president, Cell Therapy TRC, Translational Medicine & Clinical Pharmacology
“Typically, drug discovery timelines have been in the scale of decades. …. Leveraging predictive molecule invention upfront allows us to accelerate drug discovery in a way that increases our chances of progressing the best molecules.”
Payal Sheth, PhD, vice president, Discovery Biotherapeutics, Lead Discovery and Optimization
“New modalities do not come along very often, and so when they do, there is great promise. It’s one of the main motivations for our BMS scientists to begin to push the limits, to rapidly iterate and drive forth novel medications for patients who need them most.”
Neil Bence, senior vice president, Protein Homeostasis TRC, San Diego site head
